Display options
Share it on

Front Physiol. 2016 Jun 08;7:215. doi: 10.3389/fphys.2016.00215. eCollection 2016.

Greater Beta-Adrenergic Receptor Mediated Vasodilation in Women Using Oral Contraceptives.

Frontiers in physiology

Jacqueline K Limberg, Garrett L Peltonen, Rebecca E Johansson, John W Harrell, Jeremy M Kellawan, Marlowe W Eldridge, Joshua J Sebranek, Benjamin J Walker, William G Schrage

Affiliations

  1. Department of Kinesiology, University of Wisconsin Madison, WI, USA.
  2. Department of Kinesiology, University of WisconsinMadison, WI, USA; Department of Pediatrics, University of WisconsinMadison, WI, USA.
  3. Department of Anesthesiology, University of Wisconsin Madison, WI, USA.

PMID: 27375493 PMCID: PMC4896959 DOI: 10.3389/fphys.2016.00215

Abstract

BACKGROUND: β-adrenergic receptors play an important role in mitigating the pressor effects of sympathetic nervous system activity in young women. Based on recent data showing oral contraceptive use in women abolishes the relationship between muscle sympathetic nervous system activity and blood pressure, we hypothesized forearm blood flow responses to a β-adrenergic receptor agonist would be greater in young women currently using oral contraceptives (OC+, n = 13) when compared to those not using oral contraceptives (OC-, n = 10).

METHODS: Women (18-35 years) were studied during the early follicular phase of the menstrual cycle (days 1-5) or placebo phase of oral contraceptive use. Forearm blood flow (FBF, Doppler ultrasound) and mean arterial blood pressure (MAP, brachial arterial catheter) were measured at baseline and during graded brachial artery infusion of the β-adrenergic receptor agonist, Isoproterenol (ISO), as well as Acetylcholine (ACH, endothelium-dependent vasodilation) and Nitroprusside (NTP, endothelium-independent vasodilation). Forearm vascular conductance was calculated (FVC = FBF/MAP, ml/min/100 mmHg) and the rise in FVC from baseline during infusion quantified vasodilation (ΔFVC = FVCinfusion - FVCbaseline).

RESULTS: ISO increased FVC in both groups (p < 0.01) and ISO-mediated ΔFVC was greater in OC+ compared to OC- (Main effect of group, p = 0.02). Expressing data as FVC and FBF resulted in similar conclusions. FVC responses to both ACH and NTP were also greater in OC+ compared to OC-.

CONCLUSIONS: These data are the first to demonstrate greater β-adrenergic receptor-mediated vasodilation in the forearm of women currently using oral contraceptives (placebo phase) when compared to those not using oral contraceptives (early follicular phase), and suggest oral contraceptive use influences neurovascular control.

Keywords: blood flow; endothelium-dependent vasodilation; isoproterenol; neural control; smooth muscle

References

  1. Arterioscler Thromb Vasc Biol. 2005 Feb;25(2):e7-9 - PubMed
  2. Exp Physiol. 2016 Mar;101(3):349-55 - PubMed
  3. Am J Physiol Regul Integr Comp Physiol. 2001 Mar;280(3):R807-13 - PubMed
  4. Contraception. 1995 Jun;51(6):341-6 - PubMed
  5. J Appl Physiol (1985). 2005 Jun;98(6):1991-7 - PubMed
  6. Endocrinol Metab Clin North Am. 2011 Jun;40(2):419-32, ix - PubMed
  7. J Vasc Res. 1996 Mar-Apr;33(2):124-31 - PubMed
  8. J Am Coll Cardiol. 2009 Jan 20;53(3):221-31 - PubMed
  9. Arq Bras Cardiol. 2011 Apr;96(4):e81-9 - PubMed
  10. Am J Obstet Gynecol. 2000 Jul;183(1):28-33 - PubMed
  11. Int J Gynaecol Obstet. 1997 Dec;59(3):237-43 - PubMed
  12. J Clin Endocrinol Metab. 2001 Jun;86(6):2803-10 - PubMed
  13. Hypertension. 2015 Sep;66(3):590-7 - PubMed
  14. Eur J Appl Physiol. 2015 Aug;115(8):1735-46 - PubMed
  15. Front Physiol. 2015 Dec 22;6:387 - PubMed
  16. J Physiol. 2014 Dec 1;592(23):5221-33 - PubMed
  17. J Hypertens. 2003 Dec;21(12):2275-80 - PubMed
  18. Hum Reprod Update. 2006 Mar-Apr;12(2):169-78 - PubMed
  19. Am J Obstet Gynecol. 2011 Oct;205(4 Suppl):S4-8 - PubMed
  20. Physiol Rep. 2015 Jul;3(7):null - PubMed
  21. Physiol Rev. 2015 Apr;95(2):549-601 - PubMed
  22. J Physiol. 2006 Aug 1;574(Pt 3):955-65 - PubMed
  23. Arterioscler Thromb Vasc Biol. 1997 Oct;17(10):2004-9 - PubMed
  24. Am J Hypertens. 1995 Mar;8(3):249-53 - PubMed
  25. Hum Reprod. 2007 Aug;22(8):2325-34 - PubMed
  26. J Appl Physiol (1985). 2014 Nov 15;117(10 ):1207-11 - PubMed
  27. Contraception. 1996 Mar;53(3):171-6 - PubMed
  28. Steroids. 1996 Apr;61(4):166-71 - PubMed
  29. Br J Pharmacol. 1999 Apr;126(8):1872-80 - PubMed
  30. J Am Coll Cardiol. 2000 Oct;36(4):1233-8 - PubMed
  31. Am J Physiol Heart Circ Physiol. 2016 Mar 15;310(6):H756-64 - PubMed
  32. Physiol Rep. 2014 Jun 06;2(6):null - PubMed
  33. J Physiol. 2011 Mar 15;589(Pt 6):1477-88 - PubMed
  34. Contraception. 1998 Aug;58(2):75-81 - PubMed
  35. Hypertension. 1997 Oct;30(4):918-21 - PubMed
  36. Am J Physiol Renal Physiol. 2007 Nov;293(5):F1539-44 - PubMed
  37. Am J Physiol Heart Circ Physiol. 2011 Jul;301(1):H261-8 - PubMed
  38. Am J Physiol Heart Circ Physiol. 2010 May;298(5):H1626-32 - PubMed
  39. Contraception. 2011 Sep;84(3):285-90 - PubMed
  40. Am J Physiol Heart Circ Physiol. 2013 Oct 15;305(8):H1230-7 - PubMed
  41. J Physiol. 2011 Nov 1;589(Pt 21):5285-97 - PubMed
  42. Hypertension. 1998 Feb;31(2):582-8 - PubMed
  43. J Hypertens. 1992 Apr;10(4):361-6 - PubMed
  44. Contraception. 2010 Oct;82(4):366-72 - PubMed
  45. Am J Obstet Gynecol. 1999 Feb;180(2 Pt 1):334-9 - PubMed

Publication Types